Emmaus Life Sciences, Inc. (EMMA)

Emmaus Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	5	5	13	82	60	83
Market Cap Growth	-52.04%	-58.70%	-84.35%	36.76%	-27.76%	906.99%
Enterprise Value	35	36	36	110	77	101
PE Ratio	-	-1.42	-1.20	-5.16	44.42	-1.52
PS Ratio	0.15	0.18	0.70	3.99	2.60	3.66
PB Ratio	-0.13	-0.11	-0.38	-3.83	-11.10	-7.53
P/FCF Ratio	-4.07	-3.50	-2.52	-61.98	-2.10	-18.17
P/OCF Ratio	-4.12	-3.54	-2.54	-65.59	-24.54	-18.41
EV/Sales Ratio	1.19	1.21	1.95	5.33	3.31	4.44
EV/EBITDA Ratio	11.34	10.04	-5.46	-13.67	4508.43	-12.32
EV/EBIT Ratio	11.45	10.13	-5.41	-13.57	-1782.40	-12.21
EV/FCF Ratio	-24.17	-23.60	-7.05	-82.81	-2.68	-22.03
Debt / Equity Ratio	-0.65	-0.65	-0.74	-1.39	-3.50	-1.76
Debt / EBITDA Ratio	10.69	9.27	-3.81	-3.72	1116.88	-2.38
Debt / FCF Ratio	-21.78	-21.78	-4.92	-22.54	-0.66	-4.25
Quick Ratio	0.13	0.13	-0.32	0.09	0.11	0.97
Current Ratio	0.19	0.19	0.12	0.25	0.48	1.26
Asset Turnover	0.66	0.84	0.38	0.36	0.39	0.38
Interest Coverage	0.62	0.48	-1.31	-1.98	-0.01	-0.16
Return on Equity (ROE)	7.82%	7.82%	31.34%	74.34%	-24.99%	496.17%
Return on Assets (ROA)	-10.61%	-10.61%	-22.16%	-28.11%	2.28%	-92.24%
Return on Capital (ROIC)	-24.16%	-24.16%	73.23%	-72.39%	-0.48%	-53.57%
Earnings Yield	-81.98%	-70.24%	-83.03%	-19.39%	2.25%	-65.88%
FCF Yield	-33.38%	-28.60%	-39.62%	-1.61%	-47.60%	-5.51%
Buyback Yield / Dilution	-24.73%	-7.41%	-0.38%	-0.73%	-15.71%	-4776.49%
Total Shareholder Return	-24.73%	-7.41%	-0.38%	-0.73%	-15.71%	-4776.49%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.